Urology Times
SUO Annual Meeting
Spotlight
SUO Meeting: Prostate Cancer HighlightsLUGPA Annual MeetingAUA Regional MeetingsESMO Annual CongressInnovation Celebration: VideosInnovation Celebration: ArticlesUrology Times JournalUroViewAdvances in PSMA-PET Imaging for Prostate Cancer
Clinical
View MoreProstate CancerBladder CancerKidney CancerBPHNext-Generation ImagingGenomic TestingKidney StonesOAB and IncontinenceSexual DysfunctionHormone Therapy
Business
View MoreHealth Law & PolicyMalpractice ConsultPractice Management
News
Clinical
All ClinicalBenign ConditionsBladder CancerBPHFemale UrologyGenitourinary CancersHormone TherapyKidney CancerKidney StonesMen's HealthNext-Generation ImagingPediatricsProstate CancerSexual DysfunctionUrologic Surgery
Media
Podcasts'Y'tubeUroViewUTv VideosAround the PracticeBPH VideosCase-Based Peer PerspectivesMedical World NewsRapid ReadoutsUrology Medical PerspectivesViewpointsVirtual Tumor Board
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Editorial Advisory BoardSupplements and Featured PublicationsUrologists in Cancer CareUrology Times Journal
Events
Live EventsVirtual Events
CME/CE
Resources
Interactive ToolsJob BoardPartnersSponsored
Subscribe
eNewsletterPrint Subscription

  • About Us
  • Advertise
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
  • MJHLS Brand Logo

© 2023 MJH Life Sciences and Urology Times. All rights reserved.

Advertisement
SUO Annual MeetingSee All >
    Spotlight
    • SUO Meeting: Prostate Cancer Highlights
    • LUGPA Annual Meeting
    • AUA Regional Meetings
    • ESMO Annual Congress
    • Innovation Celebration: Videos
    • Innovation Celebration: Articles
    • Urology Times Journal
    • UroView
    • Advances in PSMA-PET Imaging for Prostate Cancer
    ClinicalSee All >
    • Prostate Cancer
    • Bladder Cancer
    • Kidney Cancer
    • BPH
    • Next-Generation Imaging
    • Genomic Testing
    • Kidney Stones
    • OAB and Incontinence
    • Sexual Dysfunction
    • Hormone Therapy
    BusinessSee All >
    • Health Law & Policy
    • Malpractice Consult
    • Practice Management
    • About Us
    • Advertise
    • Contact Us
    • Job Board
    • Terms and Conditions
    • Privacy
    • Do not sell my Personnal Information
    • MJHLS Brand Logo

    © 2023 MJH Life Sciences™ and Urology Times. All rights reserved.

    Cardiovascular Disease Incidence and Risk Mitigation in Patients with Locally Advanced or Metastatic Prostate Cancer on ADT

    EP1: CV Risk in Men with Prostate Cancer

    September 30th 2022

    Expert perspectives on the risk of cardiovascular disease as it exists in the context of androgen deprivation therapy (ADT) and prostate cancer.

    EP2: Examining the Data From Key Clinical Trials, and Practical Strategies

    September 30th 2022

    Shared insight on a timeline of clinical studies contextualizing cardiovascular disease in the setting of prostate cancer management.

    EP3: Strategies for Mitigating CV Risk

    September 30th 2022

    Comprehensive insight regarding strategies to mitigate cardiovascular risk in patients on therapy for prostate cancer.

    EP4: Summary and Case Study

    December 8th 2022

    Centering focus on a patient case of cardiovascular risk and prostate cancer, experts share their perspective on management strategies.

    Advertisement
    Advertisement